Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells
about
Adoptive T-cell therapies for refractory/relapsed leukemia and lymphoma: current strategies and recent advancesNovel immunotherapies in lymphoid malignanciesLymphoma Immunotherapy: Current StatusCAR T Cell Therapy: A Game Changer in Cancer TreatmentT-cell and natural killer cell therapies for hematologic malignancies after hematopoietic stem cell transplantation: enhancing the graft-versus-leukemia effectDeveloping strategies in the immunotherapy of leukemiasSorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?Adoptive T-cell therapy for LeukemiaAdoptive cell therapy for sarcomaCurrent translational and clinical practices in hematopoietic cell and gene therapyRecent Developments in Cellular Immunotherapy for HSCT-Associated ComplicationsCD19-Chimeric Antigen Receptor T Cells for Treatment of Chronic Lymphocytic Leukaemia and Acute Lymphoblastic LeukaemiaManufacture of tumor- and virus-specific T lymphocytes for adoptive cell therapiesSmart CARs engineered for cancer immunotherapyDesigning chimeric antigen receptors to effectively and safely target tumorsHLA engineering of human pluripotent stem cellsEngineered T cells for cancer treatmentChimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo.HSV-sr39TK positron emission tomography and suicide gene elimination of human hematopoietic stem cells and their progeny in humanized mice.From the mouse cage to human therapy: a personal perspective of the emergence of T-bodies/chimeric antigen receptor T cells.Identification and selective expansion of functionally superior T cells expressing chimeric antigen receptorsGenetically modified T-cell therapy for osteosarcomaChallenges and opportunities of allogeneic donor-derived CAR T cellsFully human CD19-specific chimeric antigen receptors for T-cell therapy.The nonsignaling extracellular spacer domain of chimeric antigen receptors is decisive for in vivo antitumor activity.Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy.Immunotherapy of malignant disease using chimeric antigen receptor engrafted T cellsSwitch-mediated activation and retargeting of CAR-T cells for B-cell malignancies.Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation.Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template.Chimeric antigen receptor--modified T cells: clinical translation in stem cell transplantation and beyond.CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patientsGenetically modified T cells targeting neovasculature efficiently destroy tumor blood vessels, shrink established solid tumors and increase nanoparticle deliveryPotential limitations of the NSG humanized mouse as a model system to optimize engineered human T cell therapy for cancer.Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen receptor T cells.Design and development of therapies using chimeric antigen receptor-expressing T cellsChimeric antigen receptors (CARs) from bench-to-bedside.Novel cellular therapies for leukemia: CAR-modified T cells targeted to the CD19 antigen.Redirection of T-cell effector functions for cancer therapy: bispecific antibodies and chimeric antigen receptors.CAR-modified anti-CD19 T cells for the treatment of B-cell malignancies: rules of the road.
P2860
Q26775720-7D4203C7-44F4-4463-BC9C-9244AA0F7121Q26777394-582C8477-1711-4C5A-96D2-C060B99DC3B1Q26782902-C03D3093-C4BC-4136-825B-3CD354510B48Q26822769-F9FF7A9C-1042-4649-8BC5-D0D8685E6111Q26826830-A230C8FB-81A9-4C46-B217-840944F21FB4Q26996310-1B3BF796-7F16-4239-BA11-DDCCEAE913A4Q27002575-87AFA805-94FF-43E3-8D1C-DA2B53F2F0D8Q27006934-89407A77-4241-47E4-BD06-35C1A9707427Q27009541-F034B8AB-E2A6-4FDC-B923-52DCD13C6DA6Q27024456-4A587E41-440F-4A2A-A371-AE90CBA51C43Q28079823-C9D58C84-BEFF-4E54-BFDB-F4770495FB0AQ28081600-E8EC8419-818E-47B9-8150-E323E3C6C46AQ28085769-E823B342-8B5A-41E4-BC53-08739E4E9EB2Q28087236-CBF307AE-0EC0-44F3-A4CE-B944F0B01179Q28088526-46F70641-65CA-4D92-8185-DFE41BB7BA1AQ30540471-36479B4D-81E3-42DA-B877-3115D79EA4D0Q33578792-4A2BB719-56B3-418D-98B9-7ACD416365E3Q34044910-637DA70F-9C76-4F15-B921-60E23058EC95Q34204696-2401F963-B43A-4BCF-89BB-D9300D96D5AAQ34240799-95457FA1-7C67-4696-BD31-FA7DEA76EA7BQ35689938-01483C8D-5F6E-4FE2-B5F6-68A2803ABC28Q36198232-1138AE94-D086-4817-88EE-E4607749F6FEQ36257036-9D505B67-50B2-486E-A487-CD09074FBC4FQ36281920-1B9BFC5D-5782-4A2F-BE4B-E038529CBD6EQ36408432-E6BE067A-AF7F-4C82-BB6D-C00579998494Q36430680-D81D70D7-CCA9-4E4B-9350-D00F401AEDDDQ36470354-E87BE9EA-8EDA-42C9-A674-9443C95E695BQ36551673-5A8F2E04-14E9-4A3C-AC40-53E154C72D8FQ36662079-9FFEDE57-1286-48AE-A1B6-7CE715B09FDBQ36684377-3174E6F8-CE34-4D9B-B209-03DF676754F0Q36845643-D7C655E7-3416-4589-94EB-B2EA542CC634Q36951727-5937BD83-1178-4024-B6F0-500637553B95Q37164976-35354B4B-2563-4518-83B0-9FCF531ADB8DQ37233539-A634A8B6-16D2-4BC0-BB11-5F1C8CA3E0F6Q37244349-665D3C8A-2A83-4D5F-8EEA-20DAD0D490D5Q37418289-0373BA6F-73D9-4DA1-A020-08D46B4EF6B8Q37587780-74C9BABA-0D90-44AD-8E6D-4E4235047802Q38066860-969387F7-F871-41CD-B681-23E3DB5107AEQ38096411-C6ED3613-8D8A-46F1-9485-C0C641CE5193Q38164792-0D453D13-934C-44BC-B9D1-64F35E56B663
P2860
Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Generation of CD19-chimeric an ...... pecific central memory T cells
@ast
Generation of CD19-chimeric an ...... pecific central memory T cells
@en
type
label
Generation of CD19-chimeric an ...... pecific central memory T cells
@ast
Generation of CD19-chimeric an ...... pecific central memory T cells
@en
prefLabel
Generation of CD19-chimeric an ...... pecific central memory T cells
@ast
Generation of CD19-chimeric an ...... pecific central memory T cells
@en
P2093
P2860
P1433
P1476
Generation of CD19-chimeric an ...... pecific central memory T cells
@en
P2093
Cameron J Turtle
Michael C Jensen
Rebecca A Gardner
Stanley R Riddell
Tori N Yamamoto
P2860
P356
10.1182/BLOOD-2011-07-366419
P407
P577
2011-10-26T00:00:00Z